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Fatty Acid Transport Protein 1 Can Compensate for
Fatty Acid Transport Protein 4 in the Developing
Mouse Epidermis
Meei-Hua Lin1 and Jeffrey H. Miner1,2
Fatty acid transport protein (FATP) 4 is one of a family of six FATPs that facilitate long- and very-long-chain fatty
acid uptake. Mice lacking FATP4 are born with tight, thick skin and a defective barrier; they die neonatally because
of dehydration and restricted movements. Mutations in SLC27A4, the gene encoding FATP4, cause ichthyosis
prematurity syndrome (IPS), characterized by premature birth, respiratory distress, and edematous skin with
severe ichthyotic scaling. Symptoms of surviving patients become mild, although atopic manifestations are
common. We previously showed that suprabasal keratinocyte expression of a Fatp4 transgene in Fatp4 mutant
skin rescues the lethality and ameliorates the skin phenotype. Here we tested the hypothesis that FATP1, the
closest FATP4 homolog, can compensate for the lack of FATP4 in our mouse model of IPS, as it might do
postnatally in IPS patients. Transgenic expression of FATP1 in suprabasal keratinocytes rescued the phenotype of
Fatp4mutants, and FATP1 sorted to the same intracellular organelles as endogenous FATP4. Thus, FATP1 and FATP4
likely have overlapping substrate specificities, enzymatic activities, and biological functions. These results suggest
that increasing expression of FATP1 in suprabasal keratinocytes could normalize the skin of IPS patients and
perhaps prevent the atopic manifestations.
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INTRODUCTION
The mammalian skin provides the first line of defense against
mechanical, chemical, and biological assaults and functions
as a barrier to inhibit water loss. The cutaneous permeability
barrier is mediated by the most superficial, cornified epider-
mal layer that forms from a series of differentiation and
stratification processes. At the beginning of epidermal differ-
entiation, proliferative basal keratinocytes migrate supraba-
sally and switch from a keratins 5/14-containing network to a
keratins 1/10-containing network, forming the spinous layer
(Candi et al., 2005). The granular layer above has profilaggrin-
containing keratohyalin granules that facilitate the assembly of
keratin bundles. Granulocytes form a cornified envelope
beneath the cell membrane via the cross-linking of involu-
crin (IVL), loricrin, and other proteins (Candi et al., 2005). The
cornified layer consists of dead, flattened, interdigitating
keratinocytes embedded in a lipid-rich matrix that results
from secretion and processing of lipids from lamellar bodies in
granulocytes (Breiden and Sandhoff, 2013).
Fatty acids in either a complex lipid or a free form are
crucial to the epidermal permeability barrier. Fatty acids serve
as building blocks for the complex lipids necessary to form the
permeability barrier, as signals for keratinocytes to regulate
epidermal homeostasis, and as acidifiers of the cornified layer
to promote its structural integrity and barrier function (Lin and
Khnykin, 2013). Fatty acids can be synthesized de novo by
keratinocytes or taken up from the diet or from extracutaneous
sites. Several proteins facilitate the uptake of long-chain fatty
acids in mammalian cells, including fatty acid translocase
(Coburn et al., 2001), fatty acid binding protein (Furuhashi and
Hotamisligil, 2008), and members of the fatty acid transport
protein (FATP)/very-long-chain acyl-CoA synthetase (ACS)
family (Gimeno, 2007; Anderson and Stahl, 2013). However,
the exact molecular mechanism of transport across the plasma
membrane remains unclear. Clinical findings and recent
studies in animal models suggest crucial roles for these
candidate transporters in the skin (Lin and Khnykin, 2013).
The FATP family consists of six membrane proteins that can
all facilitate uptake of fatty acids of 16–24 carbons (Coe et al.,
1999; Mihalik et al., 2002; Hall et al., 2005; Jia et al., 2007).
FATPs display ACS activity and are proposed to facilitate
uptake of fatty acids by a mechanism called vectorial acyla-
tion, whereby free fatty acids are esterified into an acyl-CoA
form after import, thus diminishing the intracellular pool of
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free fatty acids and creating a gradient across the membrane
that drives their further influx (Black and DiRusso, 2003). It is
not known whether FATPs function as inherent transporters
or whether a different protein is required to facilitate fatty
acid import. The distribution of FATPs in the skin varies
substantially: FATP1, FATP3, FATP4, and FATP6 are detected
in the epidermis and hair follicles of adult mice; FATP1 and
FATP4 are robustly expressed in subcutaneous fat; and FATP4
is the only FATP detected in sebaceous glands (Schmuth et al.,
2005).
We previously identified an autosomal recessive mouse
phenotype called wrinkle free caused by a retrotransposon
insertion into Slc27a4, the gene encoding FATP4 (Moulson
et al., 2003). Mice lacking FATP4 (herein referred to as
Fatp4 / mice) are born with tight, thick, ‘‘wrinkle free’’
skin and a defective skin barrier, whereas Fatp4þ / mice are
phenotypically normal. Fatp4 / mice die neonatally because
of dehydration and restricted movements. Similar phenotypes
occur in two independently derived Fatp4 mutants (Herrmann
et al., 2003; Tao et al., 2012). Suprabasal keratinocyte expres-
sion of a Fatp4 transgene in Fatp4 mutant skin rescues the
neonatal lethality and ameliorates the skin phenotype,
underscoring the crucial, skin-intrinsic roles of FATP4 in skin
development and function (Moulson et al., 2007).
Mutations affecting human FATP4 occur in patients with the
ichthyosis prematurity syndrome (IPS), characterized by pre-
mature birth, respiratory distress, peripheral blood eosinophi-
lia, and edematous skin with severe caseous scaling (Bygum
et al., 2008; Klar et al., 2009; Sobol et al., 2011). Symptoms of
surviving patients become mild during childhood and manifest
mainly as dry and pruritic skin, although respiratory and/or
food allergies are common (Khnykin et al., 2012). This
suggests that FATP4 is critical for the development of the
skin during the fetal and neonatal periods, but other FATPs
may compensate for the lack of FATP4 at later stages.
Here we tested the hypothesis that FATP1, the FATP with
the highest homology to FATP4, can functionally compensate
for the lack of FATP4. Our results demonstrate that transgenic
FATP1 expression in suprabasal keratinocytes rescues the
neonatal lethality and ameliorates the skin phenotype in Fatp4
mutants, similar to transgenic FATP4 expression.
RESULTS
Expression of Fatp4 and Fatp1 in the fetal skin
By in situ hybridization, Fatp4 was normally expressed in fetal
epidermis in suprabasal keratinocytes (upper left panel in
Figure 1a) and in hair follicle and sebaceous gland progenitors
(Lin et al., 2013). In contrast, Fatp4 / mice showed nuclear
localization of Fatp4 RNA in some epidermal keratinocytes,
perhaps because of mislocalization of mutant transcripts
caused by inclusion of the retrotransposon (upper middle
panel in Figure 1a) (Lin et al., 2013). FATP1 is the FATP with
the highest homology to FATP4 (Hirsch et al., 1998). Fatp1
RNA was detected in subsets of basal keratinocytes, in hair
follicle progenitors (lower left panel in Figure 1a), and in
subcutaneous adipocytes (data not shown) during fetal devel-
opment. Its epidermal expression did not appear to be affected
by the lack of FATP4 (lower middle panel in Figure 1a). Thus,
Fatp4 and Fatp1 are expressed in nearly complementary
compartments in the fetal mouse skin.
Restoration of the skin barrier in Fatp4 / ;Tg(IVL-Fatp1) mice
We showed previously that suprabasal keratinocyte expression
of a Fatp4 transgene in Fatp4 mutant skin rescues the neonatal
lethality and ameliorates the skin phenotype, underscoring the
crucial, skin-intrinsic roles of FATP4 in the development and
function of the skin (Moulson et al., 2007). To test whether
FATP1 can functionally compensate for the lack of FATP4 in
our mouse model of IPS, we generated three independent lines
of transgenic mice expressing a hemagglutinin (HA)-tagged
FATP1 under the control of the human IVL promoter. After
crossing to Fatp4þ / mice for two generations, Fatp4 / ;
Tg(IVL-Fatp1) mice were obtained. Fatp4 / ;Tg(IVL-Fatp1)
mice derived from two of the transgenic lines were viable and
fertile and showed robust Fatp1 transgene expression in
suprabasal keratinocytes (lower right panel in Figure 1a).
Although Fatp1 RNA in early hair follicle progenitors was
decreased in Fatp4 / ;Tg(IVL-Fatp1) skin (lower right panel
in Figure 1a), its expression in more differentiated follicles was
not changed (not shown). Like Fatp4 / ;Tg(IVL-Fatp4) mice
(Moulson et al., 2007), Fatp4 / ;Tg(IVL-Fatp1) mice also
displayed disheveled coat hair as early as around weaning
age, which progressed into thinning hair and/or patches of
alopecia at older ages (data not shown). Fatp4 / mice
rescued by either of the two IVL-Fatp1 lines showed
similar results; data obtained from one line are shown here.
Fatp4 / ;Tg(IVL-Fatp1) mice from the third line died
postnatally because of transgene expression in only a subset
of granular cells (data not shown).
Fatp4 / mice exhibit an abnormal permeability barrier
from E16.5 onward and show an incomplete barrier at birth;
these barrier defects are remedied by expression of a Fapt4
transgene in suprabasal keratinocytes (Moulson et al., 2007;
Lin et al., 2010). As assayed by the inward permeability of
X-Gal, forced FATP1 expression in the epidermis was also able
to normalize the defective barrier of Fatp4 / fetuses
(Figure 1b). Moreover, Fatp4 / newborns showed a sig-
nificantly higher outward transepidermal water loss compared
with Fatp4þ / controls (5.3±1.6 g m2 hour1, n¼ 9 vs.
1.1±0.9 g m2 hour1, n¼4; ***Po0.001) (Figure 1c).
However, Fatp4 / ;Tg(IVL-Fatp1) newborns displayed a
transepidermal water loss that was indistinguishable from that
of Fatp4þ / controls (1.2±0.9 g m2 hour1, n¼8;
P40.05) (Figure 1c). The statistically significant reduction in
transepidermal water loss by Fatp1 transgene expression was
also observed in Fatp4 / ;Tg(IVL-Fatp4) newborns
(Figure 1d). The permeability barrier in Fatp4þ / ;Tg(IVL-
Fatp1) and Fatp4þ / ;Tg(IVL-Fatp4) mice was indistinguish-
able from that of Fatp4þ / mice (Figure 1b–d). These results
demonstrate that forced ectopic expression of FATP1 in
Fatp4 / suprabasal keratinocytes rescues the neonatal leth-
ality and restores the permeability barrier.
Amelioration of skin phenotypes in Fatp4 / ;Tg(IVL-Fatp1) mice
Fatp4 / fetuses display epidermal hyperplasia that results
from an increased number of proliferating suprabasal cells
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(Lin et al., 2010). The hyperplasia is associated with epidermal
activation of keratin 6 expression, epidermal growth factor
receptor signaling, and phosphorylation and nuclear translo-
cation of signal transducer and activator of transcription 3
(STAT3), a downstream effector of epidermal growth factor
receptor signaling. Pharmacological inhibition of epidermal
growth factor receptor and STAT3 activation reduce skin
thickening and partially suppress the barrier abnormalities
(Lin et al., 2010). Consistent with the RNA expression pattern
of the Fatp1 transgene, HA-tagged FATP1 was detected
specifically in suprabasal keratinocytes (second row in
Figure 2). The transgenic FATP1 prevented the epidermal
hyperplasia observed in Fatp4 / mice (top row in Figure 2).
In addition, the ectopic activation of keratin 6 and STAT3 in
Fatp4 / epidermis was diminished by Fatp1 transgene
expression (bottom two rows in Figure 2). This amelioration
of Fatp4 / skin phenotypes is reminiscent of the effects of
suprabasal Fatp4 transgene expression (Moulson et al., 2007).
Amelioration of lipid abnormalities in Fatp4 / ;Tg(IVL-Fatp1)
epidermis
FATP4 is normally localized to the granular layer of the
epidermis, where barrier lipid precursors are synthesized.
During epidermal differentiation, the lipid-enriched contents
of lamellar bodies in the uppermost cells of the granular layer
are secreted into the extracellular space and processed into
ceramides, cholesterol, and fatty acids, the three major lipids
required for the permeability barrier function of the cornified
layer (Holleran et al., 2006). Epidermal lipid analyses of Fatp4
mutant newborns revealed a significantly decreased propor-
tion of ceramides with fatty acid moieties containing X26
carbon atoms and a significantly increased proportion of those
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Figure 1. Restoration of the skin barrier in Fatp4 / ;Tg(IVL-Fatp1) and Fatp4 / ;Tg(IVL-Fatp4) mice. (a) Dorsal skin sections from E16.0 littermate embryos
were subjected to in situ hybridization and counterstained with nuclear fast red. Fatp4 RNA was detected in suprabasal keratinocytes of Fatp4þ / (control) and in
nuclei of some Fatp4 / keratinocytes (top panels). Fatp1 RNA was detected in basal keratinocytes and hair follicle (asterisks) progenitors of Fatp4þ / and
Fatp4 / embryos and additionally detected in suprabasal keratinocytes of Fatp4 / ;Tg(IVL-Fatp1) embryos (lower panels). Dashed lines demarcate the dermo-
epidermal boundary. Bar¼ 50mm. (b) E17.5 littermate embryos were tested for inward X-Gal permeability. The incomplete barrier in Fatp4 / embryos was
remedied in Fatp4 / ;Tg(IVL-Fatp1) embryos (asterisk). (c, d) Newborns were tested for outward transepidermal water loss (TEWL) assays. The increased TEWL in
Fatp4 / newborns compared with Fatp4þ / controls was normalized in both Fatp4 / ;Tg(IVL-Fatp1) (c) and Fatp4 / ;Tg(IVL-Fatp4) newborns (d). Numbers
of samples (n) are indicated. ***Po0.001; *Po0.05. The TEWL readings in panels c and d were obtained from two separate Vapometers.
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containing p24 carbon atoms (Herrmann et al., 2003;
Moulson et al., 2007). These ceramide abnormalities
suggest an inability of Fatp4 mutant keratinocytes to activate
very-long-chain fatty acids to an acyl-CoA form, which could
lead to subsequent accumulation of free fatty acids inside
cells.
To investigate this hypothesis, we performed lipid analyses
by thin layer chromatography using total free, extractable
lipids isolated from newborn epidermis. Compared with
controls, Fatp4 /epidermis showed a significantly increased
amount of free fatty acids (Figure 3). Quantification of free
fatty acids in separate studies revealed 4.44±0.82mg mg 1
dry tissue in controls (n¼ 4) versus 8.80±1.75mg mg1 in
mutants (n¼ 4), (Po0.01) (Supplementary Table S1a online)
and 3.96±1.06mg mg 1 dry tissue in controls (n¼ 6) versus
6.54±0.82mg mg 1 in mutants (n¼6), (Po0.001) (Supple-
mentary Table S1b online). Furthermore, these increases were
ameliorated in both Fatp4 / ;Tg(IVL-Fatp1) mice (Figure 3a
and Supplementary Table S1a online) and Fatp4 / ;Tg(IVL-
Fatp4) mice (Figure 3b and Supplementary Table S1b online).
In contrast, the levels of cholesteryl ester, triacyglycerol, and
free cholesterol in the newborn epidermis were not signifi-
cantly affected by FATP4 deficiency (Figure 3 and Supple-
mentary Table S1 online).
Subcellular localization of endogenous FATP4 and transgenic
FATP1 in the epidermis
The subcellular localization of FATP1 and FATP4 in mamma-
lian cells has been reported to be plasma membrane and/or
intracellular organelles (Kazantzis and Stahl, 2012 and
references therein). For example, studies of stably transfected
FATP4-overexpressing cells suggest that FATP4 is an endo-
plasmic reticulum (ER)–localized ACS that is able to drive
import of fatty acids via its enzymatic activity (Milger et al.,
2006; Zhan et al., 2012). Our previous study of cultured
fibroblasts shows that endogenous FATP4 is localized to
mitochondria and to a lesser extent to ER and peroxisomes
(Jia et al., 2007). To examine whether endogenous FATP4 is
also localized to multiple organelles in the epidermis, granular
keratinocytes, which show the most intense FATP4 immuno-
staining (Lin et al., 2013), were isolated from newborn and
young pup skin and analyzed.
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Figure 2. Amelioration of skin phenotypes in Fatp4 / ;Tg(IVL-Fatp1) mice. Dorsal skin sections from E16.0 embryo littermates were subjected to hematoxylin
and eosin (H&E) staining (top row) and immunohistochemical analyses followed by counterstaining with hematoxylin (bottom three rows). The thickened
epidermis phenotype seen in Fatp4 / newborns was normalized in Fatp4 / ;Tg(IVL-Fatp1) newborns (top row). The hemagglutinin (HA)-tagged FATP1
encoded by the transgene was detected primarily in granular keratinocytes in Fatp4 / ;Tg(IVL-Fatp1) mice (second row). The ectopic expression of keratin 6 seen
in Fatp4 / newborns was diminished in Fatp4 / ;Tg(IVL-Fatp1) mice (third row). The nuclear localization of pSTAT3 (phospho-signal transducer and activator
of transcription 3) shown in Fatp4 / newborns was also diminished in Fatp4 / ;Tg(IVL-Fatp1) mice (bottom row). Dashed lines demarcate the dermo-epidermal
boundary. Bar¼ 50mm.
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By hematoxylin staining, granular keratinocytes isolated
from control mice were filled with keratohyalin granules
(lower left panel in Figure 4). Compared with controls,
granular keratinocytes from Fatp4 / newborns were smaller,
and the granules were less distinct (middle column in
Figure 4). In contrast, these abnormalities were remedied in
Fatp4 / ;Tg(IVL-Fatp4) cells and Fatp4 / ;Tg(IVL-Fatp1)
cells (right column in Figure 4). By double immunofluores-
cence staining, endogenous FATP4 in control cells was
detected in a mesh-like pattern that colocalized mainly with
the ER luminal protein calreticulin (Figure 5d–f0) and partially
with the mitochondrial membrane protein ATP synthase
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Figure 3. Amelioration of the elevated level of free fatty acids in Fatp4 / ;Tg(IVL-Fatp1) and Fatp4 / ;Tg(IVL-Fatp4) epidermis. Free, extractable lipids from
the epidermis of newborn mice were resolved by thin layer chromatography and visualized by charring the plate. The elevated level of free fatty acids seen in
Fatp4 / mice was reduced to normal in (a) Fatp4 / ;Tg(IVL-Fatp1) and (b) Fatp4 / ;Tg(IVL-Fatp4) mice. Components of the lipid standards and origin of
sample application are indicated on the left of panel a. Lipid species of the epidermis are indicated between the panels.
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Figure 4. Restoration of the keratohyalin granules in Fatp4 / ;Tg(IVL-Fatp4) and Fatp4 / ;Tg(IVL-Fatp1) mice. Granular keratinocytes-enriched cell fractions
were prepared from the epidermis of newborn littermates and stained with hematoxylin. The smaller cell size and less distinct keratohyalin granules seen in
Fatp4 / mice compared with control (Fatp4þ / ) were normalized in Fatp4 / ;Tg(IVL-Fatp4) and Fatp4 / ;Tg(IVL-Fatp1) mice. Bar¼ 10mm.
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Figure 5. Subcellular localization of endogenous FATP4 and transgenic FATP1 in granular keratinocytes. Granular keratinocytes from the epidermis of (a–i0,
m–o0) newborns or (j–l0) 1.5- or (p–u0) 5.5-day-old pups were subjected to double immunofluorescence staining with the indicated antibodies. Merged confocal
images of low and high magnification are shown in the right two columns. The mesh-like pattern of FATP4 staining in Fatp4þ /þ cells colocalized partially with the
mitochondrial membrane protein ATP synthase (a–c0; arrowheads in c0) and mainly with the endoplasmic reticulum luminal protein calreticulin (d–f0) but not with
the plasma membrane protein IL-1 receptor 1 (g–i0). The mesh-like pattern of FATP4 localization was similar to the staining pattern of calreticulin around the
filaggrin-positive granules (j–l0). The hemagglutinin (HA)-tagged FATP1 in Fatp4þ /þ ;Tg(IVL-Fatp1) cells also showed a mesh-like staining pattern that colocalized
with endogenous FATP4 (s–u0). The HA-tagged FATP1 was not detected in Fatp4þ /þ cells (m–o0). Endogenous FATP4 was not detected in Fatp4 / ;Tg(IVL-Fatp1)
cells (p–r0). Bar¼ 10mm.
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(Figure 5a–c0; arrowheads in c0). The FATP4 signals were also
observed at the nuclear surface, which is very likely the ER
membrane that is contiguous with the nuclear membrane.
Using interleukin 1 receptor 1 as a marker, we could not
detect FATP4 at the plasma membrane (Figure 5g–i0). The
mesh-like pattern of FATP4 staining was similar to the inter-
granular staining of calreticulin (Figure 5j–l0). FATP4 was not
detected in Fatp4 / cells (Figure 5p–r0 and data not shown).
As demonstrated above, transgenic expression of FATP1 in
suprabasal keratinocytes rescued the Fatp4 / neonatal
lethality and normalized most of the skin abnormalities. To
examine whether the rescuing effects of exogenous FATP1
correlated with its trafficking to the same subcellular compart-
ments as endogenous FATP4, granular keratinocytes from
Fatp4þ /þ ;Tg(IVL-Fatp1) mice were subjected to double
immunofluorescence staining with HA-tag and FATP4 anti-
bodies. As shown in Figure 5s–u0, HA-tagged transgenic
FATP1 colocalized nearly completely with endogenous
FATP4. This implies localization of transgenic FATP1 to ER
and mitochondria but not to the plasma membrane, as
observed for FATP4. This observation was confirmed by
double immunofluorescence staining in Fatp4 / ;Tg(IVL-
Fatp1) cells with HA-tag antibody and various organellar
marker antibodies (Supplementary Figure S1 online). These
results suggest that the rescuing effects of HA-FATP1 require
its sorting to the same subcellular compartments as FATP4.
DISCUSSION
Among the six mouse FATP family members, FATP1 is most
closely related to FATP4 (Herrmann et al., 2001). These two
FATPs are expressed in nearly complementary compartments
in the skin during fetal development: FATP4 in suprabasal
keratinocytes, sebaceous gland progenitors, and hair follicle
progenitors (Lin et al., 2013), and FATP1 in cell clusters within
the basal layer of the epidermis, in adipocytes of subcutaneous
fat, and in hair follicle progenitors (Figure 1). Unlike Fatp4 /
mice, knockout of Fatp1 does not lead to skin phenotypes,
despite its cutaneous expression pattern (Kim et al., 2004). In
addition, although FATP4 expression predominates in fetal
mouse epidermis, FATP1 expression predominates in adult
epidermis (Schmuth et al., 2005). The spatial and temporal
differences in expression of these two FATPs in the skin
suggest regulation to meet the metabolic requirements of
various compartments and developmental stages.
Our results demonstrate that transgenic expression of FATP1
in suprabasal keratinocytes of Fatp4 / mice, like that of
FATP4, rescues the neonatal lethality and normalizes the
permeability barrier, epidermal hyperplasia, the level of free
fatty acids, epidermal activation of keratin 6 and STAT3, and
defective keratohyalin granules. The subcellular localization
of FATP1 and FATP4 in mammalian cells has been reported
to be plasma membrane and/or intracellular organelles
(Kazantzis and Stahl, 2012 and references therein). However,
our results show that endogenous FATP4 in epidermal
keratinocytes is localized to the ER and mitochondria but
not to the plasma membrane. This suggests that in epidermal
keratinocytes FATP4 does not function as a transmembrane
transporter per se but rather facilitates fatty acid import
indirectly by activating fatty acids to an acyl-CoA form.
Studies using FATP4-overexpressing cells suggest that FATP4
is an ER-localized ACS that displays a type III signal-anchor
transmembrane domain topology, with the short N-terminal
sequence of FATP4 oriented toward the ER lumen and the
enzymatic part facing the cytosolic side (Milger et al., 2006;
Zhan et al., 2012). It remains unknown how the information in
FATP4 regulates its targeting in epidermal keratinocytes to the
ER and to the mitochondria, but our results show that exo-
genous FATP1 was sorted to these same granular keratinocyte
subcellular compartments.
Our preliminary mass spectrometry data show that the
elevated free fatty acid pool in Fatp4 / epidermis (Figure 3)
was composed of VLCFA, especially C22:0, C24:0, C24:1,
and C26:1. The increases in these VLCFA were normalized by
both Fatp1 and Fatp4 transgenes (unpublished data). Taken
together, that FATP1 could functionally compensate for the
FATP4 deficiency in Fatp4 / skin indicates that FATP1 and
FATP4 likely share similar substrate specificities and enzy-
matic activities. The presence of both genes in the mammalian
genome could relate to their partially nonoverlapping
expression patterns rather than to any significant functional
differences.
As in adult mouse epidermis, FATP1, FATP3, FATP4, and
FATP6 are also expressed in the human epidermis. Upon
barrier disruption in adult mice, the epidermal expression of
FATP6 and fatty acid translocase, another candidate transpor-
ter that facilitates the uptake of fatty acids in the epidermis, is
increased. This upregulation suggests potential roles for FATPs
in restoring the steady state of barrier lipids (Schmuth et al.,
2005). It would be important to investigate whether in IPS
patients other FATPs or other candidate transporters are
ectopically expressed in the same epidermal compartments
as endogenous FATP4 after birth to compensate for the skin
abnormalities. Given the functional similarities between
FATP1 and FATP4 revealed by our mouse studies, increasing
expression of FATP1/SLC27A1 in suprabasal keratinocytes
could be pursued as a therapy to normalize the skin pheno-
type of IPS patients and perhaps prevent the development of
atopic manifestations. Our results in mice also suggest that the
amelioration of symptoms in IPS patients postnatally might be
attributable to postnatal ectopic expression of FATP1 in the
cell layer where endogenous FATP4 is normally expressed. In
Fatp4 mutant mice, the epidermal expression of Fatp1 RNA
during fetal development (Figure 1) or at birth (data not
shown) did not appear to be increased by the lack of FATP4,
perhaps explaining their severe skin phenotype.
MATERIALS AND METHODS
Mice
Fatp4 mutant and IVL promoter–driven Fatp4 transgenic mice have
been previously described (Moulson et al., 2003, 2007). The human
IVL promoter-driven Fatp1 transgene was generated by PCR
amplification of a cDNA encoding FATP1 with an amino-terminal
HA-tag (Chiu et al., 2005) using Klentaq LA DNA polymerase (in-
house facility of Washington University) and primers that added NotI
sites to the HA-tag and to the 30 end of the cDNA. The PCR product
was purified by the Wizard SV Gel and the PCR CleanUp System
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(Promega, Madison, WI), cut with NotI, and ligated into the NotI sites
of a clone containing the human IVL promoter and the SV40
polyadenylation signal sequence (Carroll et al., 1993). The trans-
gene was liberated from the vector by digestion with SalI and purified
by the QIAEX II Gel Extraction Kit (Qiagen, Germantown, MD).
Transgenic mice were generated by microinjection of the transgene
into the pronuclei of one-cell stage B6CBAF2/J mouse embryos.
Potential founders were screened for incorporation of the transgene
by PCR using primers from two different exons of Fatp1 and examined
for expression of the transgene by immunohistochemistry with an
HA-tag antibody (see below). Embryos were dissected from pregnant
females, with the morning when the copulation plug was observed
considered embryonic day (E) 0.5. All experiments were approved by
the Washington University Animal Studies Committee.
Skin barrier assays
The inward permeability assay by X-Gal and the outward transepi-
dermal water loss assay with a Vapometer (Delfin Technologies,
Kuopio, Finland) were performed as described (Lin et al., 2010).
Immunohistochemistry
Immunohistochemical analyses on paraffin sections were performed
as described (Lin et al., 2010). The antigen retrieval method and
dilutions of primary antibodies used were as follows: EDTA and 1:50
for phospho-STAT3 (Tyr705); Trilogy and 1:50 for HA-tag (both
antibodies from Cell Signaling Technology, Beverly, MA); and
1:1,000 for keratin 6 (Covance, Princeton, NJ). Sections were coun-
terstained with hematoxylin and mounted.
In situ hybridization
Preparation of paraffin sections and in situ hybridization using
digoxigenin-UTP labeled Fatp4 and Fatp1 riboprobes were performed
as described (Moulson et al., 2007), with the hybridization tem-
perature at 60 and 55 1C, respectively.
Extraction of epidermal lipids
HPLC grade solvents were purchased from Sigma Chemical (St Louis,
MO). Free, extractable lipids were isolated from the epidermis of
newborn mice. To isolate the epidermis, the body trunk skin was
incubated in 10 mM EDTA in phosphate-buffered saline (PBS) at 37 1C
for 1.5 hours with the dermal side down. The epidermis was peeled as
a whole sheet, lyophilized, weighed, and stored at  80 1C. Lipids
were extracted from lyophilized epidermis of each newborn with
3.8 ml of chloroform/methanol/water (1/2/0.8) at room temperature
for 2 hours followed by phase separation by adding 1 ml each of
chloroform and water. After centrifugation, the lipid-enriched lower
phase was re-extracted with 1 ml of chloroform, 1 ml of methanol,
and 0.9 ml of water and recentrifuged. The lower phase was then
dried with a nitrogen evaporator (Organomation Associates, Berlin,
MA), resuspended in 200ml chloroform/methanol (2/1), and stored
under nitrogen at  20 1C.
Lipid analysis by thin layer chromatography
Silica gel 60 plates (Sigma; Merck, Darmstadt, Germany) were baked
at 120 1C for 30 minutes in an oven prior to use. To separate neutral
lipids, lipid extracts were applied to plates and resolved in a solvent
mixture of hexane/diethyl ether/acetic acid (70:30:1) in a preequili-
brated tank until the solvent front reached the top of the plate (20 cm).
Standard lipids used include the nonpolar lipid mix B, palmitic acid
(16:0) (both from Matreya, Pleasant Gap, PA), heptacosanoic acid
(27:0), and a mono-, di-, triglyceride mix (both from Sigma). Resolved
plates were dried, and the lipid spots were visualized by spraying
with 3% copper acetate in 8% phosphoric acid followed by charring
at 180 1C for 15 minutes in an oven (Macala et al., 1983). For
quantification of lipid species, lipid spots on charred thin layer
chromatographic plates were scanned and quantified in ImageJ
(http://rsbweb.nih.gov/ij/) with co-chromatographed standards in the
range of 0.5–4mg for each band. Cholesteryl oleate, triolein, and oleic
acid were used as the standards for cholesteryl ester, triacylglycerol,
and free fatty acids, respectively.
Isolation of keratinocyte fractions
The epidermis was collected from newborn mice and young pups up
to 5.5 days of age as described above. For newborns, the basal and
spinous keratinocytes–enriched fraction was obtained by incubating
the epidermis in 0.05% trypsin-EDTA (Gibco, Grand Island, NY) at
37 1C for 20 minutes in a small dish with the skin surface up followed
by manually shaking the digested epidermis in cold PBS vigorously 20
times and filtering through a 70-mm nylon cell strainer (BD Bio-
sciences, San Jose, NJ) into a tube containing cold soy bean trypsin
inhibitor (Gibco) at 0.5 mg ml 1 in PBS. The granular keratinocytes–
enriched fraction was obtained by incubating the residual epidermal
sheet in 0.25% trypsin-EDTA (Gibco) at 37 1C for 20 minutes in a
small dish with the skin surface up followed by manually shaking the
digested sheet in cold trypsin inhibitor solution vigorously 20 times
and filtering through a 100-mm nylon cell strainer (BD Biosciences).
Both cell fractions were then centrifuged at 800 r.p.m. for 5 minutes at
4 1C, resuspended in cold PBS, and spun onto slides at 400 r.p.m. for
3 minutes in a Shandon Cytospin (Thermo Scientific, Rockford, IL) to
make a cell monolayer. Slides were air dried for 10 minutes and
stored at  20 1C for up to a week.
Immunofluorescence staining
The cell monolayers were fixed in 4% paraformaldehyde in PBS for
5 minutes, permeabilized with cold methanol at  20 1C for 5 min-
utes, and blocked in 1% bovine serum albumin and 10% normal goat
serum or normal donkey serum in PBS for 30 minutes. Cells were then
incubated at 4 1C overnight with primary antibodies diluted in 1%
bovine serum albumin in PBS, incubated for 30 minutes in dark with
fluorophore-labeled secondary antibodies diluted in 1% bovine
serum albumin in PBS, counterstained with Hoechst 33258, and
mounted in 90% glycerol containing 0.1 PBS and 1 mg ml 1
P-phenylenediamine. Immunostaining with filaggrin antibody was
performed on freshly prepared cell monolayers by fixation in 4%
paraformaldehyde in PBS for 20 minutes and permeabilization in
0.5% Triton X-100 in PBS for 5 minutes. Dilutions of primary
antibodies used were as follows: 1:100 for FATP4 (Newberry et al.,
2003), calreticulin/calregulin (Santa Cruz Biotechnology, Santa Cruz,
CA), ATP synthase, beta chain (Millipore, Temecula, CA), and IL-1
receptor 1 (R&D Systems, Minneapolis, MN); 1:4000 for filaggrin and
1:50 for mouse HA-tag (Covance); and 1:50 for rabbit HA-tag (Cell
Signaling Technology). Fluorophore-conjugated secondary antibodies
were used at a 1:400 dilution and included the following: goat Alexa
488 anti-rabbit, goat Cy3 anti-mouse (both from Invitrogen), donkey
Alexa 488 anti-rabbit, and donkey Cy3 anti-goat (both from Jackson
Immunoresearch, West Grove, PA). Images were acquired with a
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Nikon C1 confocal system (Nikon Instruments, Melville, NY) and
analyzed in the Nikon Elements software (Nikon Instruments).
Statistical analysis
Two-tailed, unpaired Student’s t-tests were used to determine statis-
tical significance in the assays. Differences were considered signifi-
cant when Po0.05.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
This work was supported by the National Institutes of Health grant
R01AR049269 (to JHM). We thank Darlene Stewart and Teresa Tolley for
assistance with histology, Gloriosa Go for transgene preparation, Jennifer
Richardson for mouse genotyping, and the Mouse Genetics Core for generating
transgenic mice and for husbandry. Production of Fatp1 transgenic mice was
supported by the Digestive Diseases Research Core Center (P30DK052574).
The animals were housed in a facility supported by the NCRR grant
C06RR015502.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at http://
www.nature.com/jid
REFERENCES
Anderson CM, Stahl A (2013) SLC27 fatty acid transport proteins. Mol Aspects
Med 34:516–28
Black PN, DiRusso CC (2003) Transmembrane movement of exogenous long-
chain fatty acids: proteins, enzymes, and vectorial esterification. Micro-
biol Mol Biol Rev 67:454–72
Breiden B, Sandhoff K (2013) The role of sphingolipid metabolism in cutaneous
permeabilitybarrier formation. Biochim Biophys Acta 1841:441–52
Bygum A, Westermark P, Brandrup F (2008) Ichthyosis prematurity syndrome: a
well-defined congenital ichthyosis subtype. J Am Acad Dermatol 59:S71–4
Candi E, Schmidt R, Melino G (2005) The cornified envelope: a model of cell
death in the skin. Nat Rev Mol Cell Biol 6:328–40
Carroll JM, Albers KM, Garlick JA et al. (1993) Tissue- and stratum-specific
expression of the human involucrin promoter in transgenic mice. Proc
Natl Acad Sci USA 90:10270–4
Chiu HC, Kovacs A, Blanton RM et al. (2005) Transgenic expression of fatty
acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ
Res 96:225–33
Coburn CT, Hajri T, Ibrahimi A et al. (2001) Role of CD36 in membrane
transport and utilization of long-chain fatty acids by different tissues. J Mol
Neurosci 16:117–21
Coe NR, Smith AJ, Frohnert BI et al. (1999) The fatty acid transport protein
(FATP1) is a very long chain acyl-CoA synthetase. J Biol Chem
274:36300–4
Furuhashi M, Hotamisligil GS (2008) Fatty acid-binding proteins: role in
metabolic diseases and potential as drug targets. Nat Rev Drug Discov
7:489–503
Gimeno RE (2007) Fatty acid transport proteins. Curr Opin Lipidol 18:271–6
Hall AM, Wiczer BM, Herrmann T et al. (2005) Enzymatic properties of
purified murine fatty acid transport protein 4 and analysis of acyl-CoA
synthetase activities in tissues from FATP4 null mice. J Biol Chem
280:11948–54
Herrmann T, Buchkremer F, Gosch I et al. (2001) Mouse fatty acid transport
protein 4 (FATP4): characterization of the gene and functional assessment
as a very long chain acyl-CoA synthetase. Gene 270:31–40
Herrmann T, van der Hoeven F, Grone HJ et al. (2003) Mice with targeted
disruption of the fatty acid transport protein 4 (Fatp 4, Slc27a4) gene show
features of lethal restrictive dermopathy. J Cell Biol 161:1105–15
Hirsch D, Stahl A, Lodish HF (1998) A family of fatty acid transporters
conserved from mycobacterium to man. Proc Natl Acad Sci USA
95:8625–9
Holleran WM, Takagi Y, Uchida Y (2006) Epidermal sphingolipids: metabo-
lism, function, and roles in skin disorders. FEBS Lett 580:5456–66
Jia Z, Moulson CL, Pei Z et al. (2007) Fatty acid transport protein 4 is the
principal very long chain fatty acyl-CoA synthetase in skin fibroblasts.
J Biol Chem 282:20573–83
Kazantzis M, Stahl A (2012) Fatty acid transport proteins, implications in
physiology and disease. Biochim Biophys Acta 1821:852–7
Khnykin D, Ronnevig J, Johnsson M et al. (2012) Ichthyosis prematurity
syndrome: clinical evaluation of 17 families with a rare disorder of lipid
metabolism. J Am Acad Dermatol 66:606–16
Kim JK, Gimeno RE, Higashimori T et al. (2004) Inactivation of fatty acid
transport protein 1 prevents fat-induced insulin resistance in skeletal
muscle. J Clin Invest 113:756–63
Klar J, Schweiger M, Zimmerman R et al. (2009) Mutations in the fatty acid
transport protein 4 gene cause the ichthyosis prematurity syndrome. Am J
Hum Genet 85:248–53
Lin MH, Chang KW, Lin SC et al. (2010) Epidermal hyperproliferation in mice
lacking fatty acid transport protein 4 (FATP4) involves ectopic EGF
receptor and STAT3 signaling. Dev Biol 344:707–19
Lin MH, Hsu FF, Miner JH (2013) Requirement of fatty acid transport protein 4
for development, maturation, and function of sebaceous glands in a
mouse model of ichthyosis prematurity syndrome. J Biol Chem 288:
3964–76
Lin MH, Khnykin D (2013) Fatty acid transporters in skin development,
function and disease. Biochim Biophys Acta 1841:362–8
Macala LJ, Yu RK, Ando S (1983) Analysis of brain lipids by high performance
thin-layer chromatography and densitometry. J Lipid Res 24:1243–50
Mihalik SJ, Steinberg SJ, Pei Z et al. (2002) Participation of two members of the
very long-chain acyl-CoA synthetase family in bile acid synthesis and
recycling. J Biol Chem 277:24771–9
Milger K, Herrmann T, Becker C et al. (2006) Cellular uptake of fatty acids
driven by the ER-localized acyl-CoA synthetase FATP4. J Cell Sci
119:4678–88
Moulson CL, Lin MH, White JM et al. (2007) Keratinocyte-specific expression
of fatty acid transport protein 4 rescues the wrinkle-free phenotype in
Slc27a4/Fatp4 mutant mice. J Biol Chem 282:15912–20
Moulson CL, Martin DR, Lugus JJ et al. (2003) Cloning of wrinkle-free, a
previously uncharacterized mouse mutation, reveals crucial roles for fatty
acid transport protein 4 in skin and hair development. Proc Natl Acad Sci
USA 100:5274–9
Newberry EP, Xie Y, Kennedy S et al. (2003) Decreased hepatic triglyceride
accumulation and altered fatty acid uptake in mice with deletion of the
liver fatty acid-binding protein gene. J Biol Chem 278:51664–72
Schmuth M, Ortegon AM, Mao-Qiang M et al. (2005) Differential expression of
fatty acid transport proteins in epidermis and skin appendages. J Invest
Dermatol 125:1174–81
Sobol M, Dahl N, Klar J (2011) FATP4 missense and nonsense mutations
cause similar features in Ichthyosis Prematurity Syndrome. BMC Res
Notes 4:90
Tao J, Koster MI, Harrison W et al. (2012) A spontaneous Fatp4/Scl27a4 splice
site mutation in a new murine model for congenital ichthyosis. PLoS One
7:e50634
Zhan T, Poppelreuther M, Ehehalt R et al. (2012) Overexpressed FATP1,
ACSVL4/FATP4 and ACSL1 increase the cellular fatty acid uptake of 3T3-
L1 adipocytes but are localized on intracellular membranes. PLoS One
7:e45087
M-H Lin and JH Miner
FATP1 Can Compensate for FATP4
470 Journal of Investigative Dermatology (2015), Volume 135
